Key facts
- AMBOSS’s last known valuation is $867.6M (Apr 2025).
- It has raised $321.6M; the latest was Later Stage VC ($260.3M) in Apr 2025.
- Notable investors include Draper Associates, Partech, Cherry Ventures, Lightrock, Project A Ventures — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for AMBOSS
- ·The full record, as it builds
Funding rounds
No funding rounds for AMBOSS are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AMBOSS
Developer of a learning application designed to provide global access to a holistic platform for medical students. The company's application provides all the information on audited diseases, including drawings, pictures, and videos, along with a clinic database that offers suitable clinics, their specialist departments, important contact persons, and working conditions on-site, enabling medical students and professionals to get help in their studies, exams, and professional life.
- Sector
- Healthcare
- HQ
- Berlin, Germany
- Founded
- 2012
- Employees
- 500
- Website
- amboss.com/
- Ownership
- Privately Held (backing)
AMBOSS doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AMBOSS shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AMBOSS in its N-PORT filings yet. We sweep new filings monthly.